Universal definition and classification of heart failure: A report of the Heart Failure Society of America, Heart Failure Association of the European Society of Cardiology, Japanese Heart Failure Society and Writing Committee of the Universal Definition of Heart Failure

Substance and Substrate

(2020) Biykem Bozkurt et al.   CIRCULATION

Heart Disease and Stroke Statistics—2020 Update: A Report From the American Heart Association

(2020) Salim S. Virani et al.   CIRCULATION

Ejection fraction in heart failure revisited- where does the evidence start?

(2020) Michael Böhm et al.   EUROPEAN HEART JOURNAL

Estimating lifetime benefits of comprehensive disease-modifying pharmacological therapies in patients with heart failure with reduced ejection fraction: a comparative analysis of three randomised controlled trials

(2020) Muthiah Vaduganathan et al.   LANCET

Vericiguat in Patients with Heart Failure and Reduced Ejection Fraction

(2020) Paul W. Armstrong et al.   NEW ENGLAND JOURNAL OF MEDICINE

Prevalence and determinants of the precursor stages of heart failure: results from the population-based STAAB cohort study

(2020) Caroline Morbach et al.   European Journal of Preventive Cardiology

Natriuretic Peptides as Inclusion Criteria in Clinical Trials

(2020) Nasrien E. Ibrahim et al.   JACC-Heart Failure

Risk Profiles in Heart Failure

(2020) Stephen J. Greene et al.   Circulation-Heart Failure

Heart Failure With Recovered Left Ventricular Ejection Fraction

(2020) Jane E. Wilcox et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Endpoints in Heart Failure Drug Development

(2020) Mona Fiuzat et al.   JACC-Heart Failure

Cardiovascular and Renal Outcomes with Empagliflozin in Heart Failure

(2020) Milton Packer et al.   NEW ENGLAND JOURNAL OF MEDICINE

Dapagliflozin for Heart Failure with Preserved Ejection Fraction: Will the DELIVER Study Deliver?

(2020) David M. Williams et al.   Diabetes Therapy

Cardiac Myosin Activation with Omecamtiv Mecarbil in Systolic Heart Failure

(2020) John R. Teerlink et al.   NEW ENGLAND JOURNAL OF MEDICINE

Standardized Definitions for Evaluation of Heart Failure Therapies: Scientific Expert Panel From the Heart Failure Collaboratory and Academic Research Consortium

(2020) William T. Abraham et al.   JACC-Heart Failure

2021 ACC/AHA Key Data Elements and Definitions for Heart Failure

(2020) Biykem Bozkurt et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Adherence to self-care recommendations and associated factors among adult heart failure patients. From the patients’ point of view

(2019) Mohammed Assen Seid et al.   PLoS One

Longitudinal Titration of Medical Therapy for Heart Failure with Reduced Ejection Fraction: CHAMP-HF Registry

(2019) Stephen J. Greene et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

2019 AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation

(2019) Craig T. January et al.   CIRCULATION

SCAI clinical expert consensus statement on the classification of cardiogenic shock

(2019) David A. Baran et al.   CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS

Reasons for Lack of Improvement in Treatment With Evidence-Based Therapies in Heart Failure

(2019) Biykem Bozkurt   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Prevention or Procrastination for Heart Failure?

(2019) John G.F. Cleland et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Heart Failure Association of the European Society of Cardiology practical guidance on the use of natriuretic peptide concentrations

(2019) Christian Mueller et al.   EUROPEAN JOURNAL OF HEART FAILURE

Heart Failure Risk Stratification and Efficacy of Sodium-Glucose Cotransporter-2 Inhibitors in Patients With Type 2 Diabetes Mellitus

(2019) David D. Berg et al.   CIRCULATION

JCS 2017/JHFS 2017 Guideline on Diagnosis and Treatment of Acute and Chronic Heart Failure　― Digest Version ―

(2019) Hiroyuki Tsutsui et al.   CIRCULATION JOURNAL

Evaluation of the effects of sodium–glucose co‐transporter 2 inhibition with empagliflozin on morbidity and mortality in patients with chronic heart failure and a preserved ejection fraction: rationale for and design of the EMPEROR‐Preserved Trial

(2019) Stefan D. Anker et al.   EUROPEAN JOURNAL OF HEART FAILURE

Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction

(2019) John J.V. McMurray et al.   NEW ENGLAND JOURNAL OF MEDICINE

Angiotensin–Neprilysin Inhibition in Heart Failure with Preserved Ejection Fraction

(2019) Scott D. Solomon et al.   NEW ENGLAND JOURNAL OF MEDICINE

Sacubitril/Valsartan Across the Spectrum of Ejection Fraction in Heart Failure

(2019) Scott D. Solomon et al.   CIRCULATION

Symptom perception in heart failure: a scoping review on definition, factors and instruments

(2019) Gabrielle Cécile Santos et al.   European Journal of Cardiovascular Nursing

2019 ACC Expert Consensus Decision Pathway on Risk Assessment, Management, and Clinical Trajectory of Patients Hospitalized With Heart Failure

(2019) Steven M. Hollenberg et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

2017 Cardiovascular and Stroke Endpoint Definitions for Clinical Trials

(2018) Karen A. Hicks et al.   CIRCULATION

Mortality associated with heart failure with preserved vs. reduced ejection fraction in a prospective international multi-ethnic cohort study

(2018) Carolyn S P Lam et al.   EUROPEAN HEART JOURNAL

Heart failure with mid-range ejection fraction in CHARM: characteristics, outcomes and effect of candesartan across the entire ejection fraction spectrum

(2018) Lars H. Lund et al.   EUROPEAN JOURNAL OF HEART FAILURE

Heart failure with preserved ejection fraction: controversies, challenges and future directions

(2018) Rosita Zakeri et al.   HEART

Carvedilol for Prevention of Chemotherapy-Related Cardiotoxicity

(2018) Mônica Samuel Avila et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Outpatient Worsening Heart Failure as a Target for Therapy

(2018) Stephen J. Greene et al.   JAMA Cardiology

National Heart Foundation of Australia and Cardiac Society of Australia and New Zealand: Guidelines for the Prevention, Detection, and Management of Heart Failure in Australia 2018

(2018) John J. Atherton et al.   Heart Lung and Circulation

Fourth Universal Definition of Myocardial Infarction (2018)

(2018) Kristian Thygesen et al.   CIRCULATION

Withdrawal of pharmacological treatment for heart failure in patients with recovered dilated cardiomyopathy (TRED-HF): an open-label, pilot, randomised trial

(2018) Brian P Halliday et al.   LANCET

Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes

(2018) Stephen D. Wiviott et al.   NEW ENGLAND JOURNAL OF MEDICINE

Beta-blockers for heart failure with reduced, mid-range, and preserved ejection fraction: an individual patient-level analysis of double-blind randomized trials

(2017) John G F Cleland et al.   EUROPEAN HEART JOURNAL

Epidemiology, pathophysiology and clinical outcomes for heart failure patients with a mid-range ejection fraction

(2017) Ashish Rastogi et al.   EUROPEAN JOURNAL OF HEART FAILURE

Epidemiology and one-year outcomes in patients with chronic heart failure and preserved, mid-range and reduced ejection fraction: an analysis of the ESC Heart Failure Long-Term Registry

(2017) Ovidiu Chioncel et al.   EUROPEAN JOURNAL OF HEART FAILURE

Clinical phenotypes and outcome of patients hospitalized for acute heart failure: the ESC Heart Failure Long-Term Registry

(2017) Ovidiu Chioncel et al.   EUROPEAN JOURNAL OF HEART FAILURE

Characterization of heart failure patients with mid-range left ventricular ejection fraction-a report from the CHART-2 Study

(2017) Kanako Tsuji et al.   EUROPEAN JOURNAL OF HEART FAILURE

Drug treatment effects on outcomes in heart failure with preserved ejection fraction: a systematic review and meta-analysis

(2017) Sean Lee Zheng et al.   HEART

Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes

(2017) Bruce Neal et al.   NEW ENGLAND JOURNAL OF MEDICINE

The MELD-Plus: A generalizable prediction risk score in cirrhosis

(2017) Uri Kartoun et al.   PLoS One

Current Diagnostic and Treatment Strategies for Specific Dilated Cardiomyopathies: A Scientific Statement From the American Heart Association

(2016) Biykem Bozkurt et al.   CIRCULATION

Contributory Risk and Management of Comorbidities of Hypertension, Obesity, Diabetes Mellitus, Hyperlipidemia, and Metabolic Syndrome in Chronic Heart Failure: A Scientific Statement From the American Heart Association

(2016) Biykem Bozkurt et al.   CIRCULATION

Prevalence of lactic acidaemia in patients with advanced heart failure and depressed cardiac output

(2016) Luigi Adamo et al.   EUROPEAN JOURNAL OF HEART FAILURE

Silent disease progression in clinically stable heart failure

(2016) Hani N. Sabbah   EUROPEAN JOURNAL OF HEART FAILURE

2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure

(2016) Piotr Ponikowski et al.   EUROPEAN JOURNAL OF HEART FAILURE

Cardiac resynchronization therapy in chronic heart failure with moderately reduced left ventricular ejection fraction: Lessons from the Multicenter InSync Randomized Clinical Evaluation MIRACLE EF study

(2016) Cecilia Linde et al.   INTERNATIONAL JOURNAL OF CARDIOLOGY

Characteristics and Course of Heart Failure Stages A–B and Determinants of Progression – design and rationale of the STAAB cohort study

(2016) Martin Wagner et al.   European Journal of Preventive Cardiology

Efficacy of Sacubitril/Valsartan Relative to a Prior Decompensation

(2016) Scott D. Solomon et al.   JACC-Heart Failure

Comparison of Approaches for Heart Failure Case Identification From Electronic Health Record Data

(2016) Saul Blecker et al.   JAMA Cardiology

Influence of ejection fraction on outcomes and efficacy of spironolactone in patients with heart failure with preserved ejection fraction

(2015) Scott D. Solomon et al.   EUROPEAN HEART JOURNAL

Recommendations on pre-hospital & early hospital management of acute heart failure: a consensus paper from the Heart Failure Association of the European Society of Cardiology, the European Society of Emergency Medicine and the Society of Academic Emergenc

(2015) Alexandre Mebazaa et al.   EUROPEAN JOURNAL OF HEART FAILURE

Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes

(2015) Bernard Zinman et al.   NEW ENGLAND JOURNAL OF MEDICINE

KDOQI US Commentary on the 2012 KDIGO Clinical Practice Guideline for the Evaluation and Management of CKD

(2014) Lesley A. Inker et al.   AMERICAN JOURNAL OF KIDNEY DISEASES

Temporal Trends in the Population Attributable Risk for Cardiovascular Disease

(2014) Susan Cheng et al.   CIRCULATION

Recognizing Worsening Chronic Heart Failure as an Entity and an End Point in Clinical Trials

(2014) Javed Butler et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Disparities in Heart Failure Care

(2014) Sean P. Pinney   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

The MOGE(S) Classification of Cardiomyopathy for Clinicians

(2014) Eloisa Arbustini et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Spironolactone for Heart Failure with Preserved Ejection Fraction

(2014) Bertram Pitt et al.   NEW ENGLAND JOURNAL OF MEDICINE

Angiotensin–Neprilysin Inhibition versus Enalapril in Heart Failure

(2014) John J.V. McMurray et al.   NEW ENGLAND JOURNAL OF MEDICINE

Evaluation for liver transplantation in adults: 2013 practice guideline by the American Association for the Study of Liver Diseases and the American Society of Transplantation

(2013) Paul Martin et al.   HEPATOLOGY

Natriuretic Peptide–Based Screening and Collaborative Care for Heart Failure

(2013) Mark Ledwidge et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

B-Type Natriuretic Peptide and Prognosis in Heart Failure Patients With Preserved and Reduced Ejection Fraction

(2013) Dirk J. van Veldhuisen et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Updated Clinical Classification of Pulmonary Hypertension

(2013) Gerald Simonneau et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Heart Failure

(2013) Eugene Braunwald   JACC-Heart Failure

Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease

(2012) Jørgen Vestbo et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

ACCF/AHA/AMA-PCPI 2011 Performance Measures for Adults With Heart Failure

(2012) et al.   CIRCULATION

Predicting survival in heart failure: a risk score based on 39 372 patients from 30 studies

(2012) Stuart J. Pocock et al.   EUROPEAN HEART JOURNAL

Cardiac Troponin T Measured by a Highly Sensitive Assay Predicts Coronary Heart Disease, Heart Failure, and Mortality in the Atherosclerosis Risk in Communities Study

(2011) Justin T. Saunders et al.   CIRCULATION

Forecasting the Future of Cardiovascular Disease in the United States

(2011) Paul A. Heidenreich et al.   CIRCULATION

Progression of preclinical diastolic dysfunction to the development of symptoms

(2010) D. D Correa de Sa et al.   HEART

Association of Serial Measures of Cardiac Troponin T Using a Sensitive Assay With Incident Heart Failure and Cardiovascular Mortality in Older Adults

(2010) Christopher R. deFilippi et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

INTERMACS Profiles of Advanced Heart Failure: The Current Picture

(2009) Lynne Warner Stevenson et al.   JOURNAL OF HEART AND LUNG TRANSPLANTATION